In light of the recent temporary suspension of Novartis vaccine products (Agriflu and Fluad), Interior Health wishes to advise the public that their public flu clinics will continue as scheduled using their primary vaccine product Vaxigrip.
On Oct. 26, Health Canada issued a voluntary suspension of the use of Novartis influenza vaccines due to the presence of small particles found in the vaccines in Europe. The suspension is a precautionary measure. B.C. has temporarily suspended the use of these vaccine products.
The public can be assured that all lots of the Novartis vaccines received in B.C. had passed Health Canada’s inspection systems with no concerns and that there have been no reports in Canada or internationally of any increased side effects or health problems from the Novartis vaccines.
Interior Health reports that Novartis products comprise less than 10 per cent of the vaccine supply in Interior Health. Interior Health has been using another vaccine product for the majority of this year’s influenza vaccination campaign which is not affected by the suspension. This product will also continue to be available through community vaccine providers such as doctors and pharmacists.
For information on the influenza vaccine and to find a flu clinic near you visit: www.interiorhealth.ca/FluClinics
